Literature DB >> 16108012

Brisk deep-tendon reflexes as a distinctive phenotype in an Argentinean spinocerebellar ataxia type 2 pedigree.

Alberto L Rosa1, Irma Molina, Valeria Kowaljow, Cecilia B Conde.   

Abstract

Slow saccades, postural/intention tremor, peripheral neuropathy, and decreased deep-tendon reflexes are valuable neurological signs for clinical suspicion of spinocerebellar ataxia type 2 (SCA2). We report the presence of abnormally brisk deep-tendon reflexes in nonsymptomatic carriers and mildly and severely affected subjects of a large Argentinean SCA2 pedigree. The identification of this distinctive SCA2 phenotype in an entire pedigree reinforces the current concept that clinical algorithms are of limited value as indicators for genetic testing in SCA. Combined with published pedigrees of SCA2 manifesting as levodopa-responsive parkinsonism, this finding suggests that modifier genes could influence the clinical phenotype of SCA2. Copyright (c) 2005 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16108012     DOI: 10.1002/mds.20636

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

Review 1.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

2.  Spinocerebellar ataxia type 2 (SCA2) in an Egyptian family presenting with polyphagia and marked CAG expansion in infancy.

Authors:  Alice Abdel-Aleem; Maha S Zaki
Journal:  J Neurol       Date:  2008-02-26       Impact factor: 4.849

3.  Atypical Phenotype in a Spinocerebellar Ataxia Type 2 Kindred.

Authors:  Shweta Prasad; Vikram V Holla; Pramod Kumar Pal
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-08-04

4.  Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers.

Authors:  Luis Velázquez-Perez; Rosalinda Díaz; Ruth Pérez-González; Nalia Canales; Roberto Rodríguez-Labrada; Jacquelín Medrano; Gilberto Sánchez; Luis Almaguer-Mederos; Cira Torres; Juan Fernandez-Ruiz
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.